Management of immunosuppression and antiviral treatment before and after heart transplant for HIV-associated dilated cardiomyopathy

International Journal of Immunopathology and Pharmacology

Volumn 27, Issue 1, 2014, Pages 113-120

  Durante Mangoni, E ^a   Maiello, C ^a   Limongelli, G ^a   Sbreglia, C ^b   Pinto, D ^a   Amarelli, C ^a   Pacileo, G ^a   Perrella, A ^b   Agrusta, F ^a   Romano, G ^a   Marra, C ^a   Di Giambenedetto, S ^c   Nappi, G ^a   Utili, R ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

Antiviral agents; Immunodeficiency; Immunosuppression; Pharmacokinetics

Indexed keywords

ACETYLSALICYLIC ACID; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CANRENOATE POTASSIUM; CARVEDILOL; CD4 ANTIGEN; CD8 ANTIGEN; COTRIMOXAZOLE; CYCLOSPORIN A; DIGOXIN; DIURETIC AGENT; EFAVIRENZ; EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; EVEROLIMUS; FLUINDOSTATIN; FUROSEMIDE; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; INOTROPIC AGENT; LAMIVUDINE; LISINOPRIL; METHYLPREDNISOLONE; OMEGA POLIENOIC ACID; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID; VASODILATOR AGENT; VIRUS ANTIBODY; VIRUS DNA; VIRUS RNA; ZIDOVUDINE; ANTIRETROVIRUS AGENT; CYCLOSPORIN;

ACUTE GRAFT REJECTION; ADULT; ANTIVIRAL THERAPY; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CASE REPORT; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CLINICAL PROTOCOL; CONGESTIVE CARDIOMYOPATHY; CYTOMEGALOVIRUS; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG MONITORING; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; EPSTEIN BARR VIRUS; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HEART GRAFT; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE BIOPSY; HEART VENTRICLE EXTRASYSTOLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIV ASSOCIATED DILATED CARDIOMYOPATHY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MALE; MINNESOTA LIVING WITH HEART FAILURE QUESTIONNAIRE; NEOPLASM; OPPORTUNISTIC INFECTION; PAROXYSMAL DYSPNEA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RECURRENT DISEASE; RISK REDUCTION; STAGING; THORAX RADIOGRAPHY; ULTRAVIOLET RADIATION; VIRAL CLEARANCE; WORLD HEALTH ORGANIZATION; DYSPNEA; HEART TRANSPLANTATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; SLEEP DISORDERED BREATHING; DRUG INTERACTION; IMMUNOLOGY; LETTER; TREATMENT OUTCOME; VIROLOGY;

ADULT; ANTI-HIV AGENTS; CARDIOMYOPATHY, DILATED; DRUG INTERACTIONS; HEART TRANSPLANTATION; HIV INFECTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; TREATMENT OUTCOME;

EID: 84900537441     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201402700115     Document Type: Article

References (27)

1. Simon V, Ho DD, Karim QA. HIV/AIDS epidemiology, pathogenesis, prevention and treatment. Lancet 2006; 368:489-504. (Pubitemid 44142771)
2. Prendergast BD. HIV and cardiovascular medicine. Heart 2003; 89:793-800. (Pubitemid 36760651)
3. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Cardiac involvement in the acquired immunodeficiency syndrome: a multicenter clinical-pathological study. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS Investigators. AIDS Res Hum Retroviruses 1998; 14:1071-77.
4. Rerkpattanapipat P, Wongpraparut N, Jacobs LE, Kotler MN. Cardiac manifestations of acquired immunodeficiency syndrome. Arch Intern Med 2000; 160:602-8. (Pubitemid 30140409)
5. Roland ME, Havlir DV. Responding to organ failure in HIV-infected patients. N Engl J Med 2003; 348:2279-81. (Pubitemid 36638100)
6. Roland ME, Barin B, Carlson L, et al. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant 2008; 8:355-65.
7. Calabrese LH, Albrecht M, Young J, McCarthy P, Haug M, Jarcho J, Zackin R. Successful cardiac transplantation in an HIV-1-infected patient with advanced disease. N Engl J Med 2003; 348:2323-28. (Pubitemid 36638106)
8. Bisleri G, Morgan JA, Deng MC, Mancini DM, Oz MC. Should HIV-positive recipients undergo heart transplantation? Thorac Cardiovasc Surg 2003; 126:1639-40. (Pubitemid 37449201)
9. Uriel N, Jorde UP, Cotarlan V, Colombo PC, Farr M, Restaino Sw, Lietz K, Naka Y, Deng MC, Mancini D. Heart transplantation in human immunodeficiency virus-positive patients. J Heart Lung Transplant 2009; 28:667-69.
10. Durante-Mangoni E, Maiello C, Sbreglia C. A European first: successful heart transplant in a human immunodeficiency virus-positive recipient. J Heart Lung Transplant 2011; 30:845.
11. Eisen HJ, Tuzcu EM, Dorent R, et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 2003; 349:847-58. (Pubitemid 37025404)
12. Fiocchi R, Sebastiani R, Radavelli E, Gamba A. Everolimus-based immunosuppression versus conventional treatment in long-term heart transplanted patients: three years results of a prospective randomized trial. J Heart Lung Transplant 2011; 30(S):8.
13. Wyatt CM, Klotman PE, D'Agati VD. HIV-associated nephropathy: clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy. Semin Nephrol 2008; 28:513-22.
14. Castel MA, Pérez-Villa F, Miró JM. Heart transplantation in HIV-infected patients: more cases in Europe. J Heart Lung Transplant 2011; 30:1418.
15. Herskowitz A, Vlahov D, Willoughby S, Chaisson RE, Schulman SP, Neumann DA, Baughman KL. Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection. Am J Cardiol 1993; 71:955-58. (Pubitemid 23118068)
16. Herskowitz A, Wu TC, Willoughby SB, Vlahov D, Ansari AA, Beschorner WE, Baughman KL. Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol 1994; 24:1025-32. (Pubitemid 24306414)
17. Anderson DW, Virmani R, Reilly JM, et al. Prevalent myocarditis at necropsy in the acquired immunodeficiency syndrome. J Am Coll Cardiol 1988; 11:792-99. (Pubitemid 18092188)
18. Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 1990; 322:1098-105. (Pubitemid 20149526)
19. Lewis W, Grupp IL, Grupp G, Hoit B, Morris R, Samarel AM, Bruggeman L, Klotman P. Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine. Lab Invest 2000; 80:187-97. (Pubitemid 30120971)
20. Cardoso JS, Moura B, Martins L, Mota-Miranda A, Rocha Goncalves F, Lecour H. Left ventricular dysfunction in human immunodeficiency virus (HIV)-infected patients. Int J Cardiol 1998; 63:37-45. (Pubitemid 28060224)
21. Weiss JR, Pietra GG, Scharf SM. Primary pulmonary hypertension and the human immunodeficiency virus. Report of two cases and a review of the literature. Arch Intern Med 1995; 155:2350-54.
22. Pellicelli AM, Barbara G, Palmieri F, et al. Primary pulmonary hypertension in HIV patients: a systematic review. Angiology 2011; 52:31-41.
23. Friis-Moller N, Sabin CA, Weber R, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003; 349:1993-2003.
24. Worm SW, Kamara DA, Reiss P, et al. Elevated triglycerides and risk of myocardial infarction in HIV-positive persons. AIDS 2011; 25:1497-504.
25. Sabin CA, D'Arminio Monforte A, Friis-Moller N, et al. Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction. Clin Infect Dis 2008; 46:1101-10. (Pubitemid 351589879)
26. Bergersen BM, Sandvik L, Dunlop O, Birkeland K, Bruun JN. Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naive and HIV-negative controls: results from a Norwegian study of 721 patients. Eur J Clin Microbiol Infect Dis 2003; 22:731-36. (Pubitemid 38019313)
27. Smith CJ, Levy I, Sabin CA, Kaya E, Johnson MA, Lipman MC. Cardiovascular disease risk factors and antiretroviral therapy in an HIV-positive UK population. HIV Med 2004; 5:88-92. (Pubitemid 38404661)